How We Work
At ReportedHealth, we commit ourselves to understanding the healthcare asset with the intent to develop a clear bespoke value story to identified stakeholders: Clinicians/HCPs, Patients, Payers & Policy Makers. This approach is driven solely by the desire to see access granted to patients using established research methods.
Oncology Asset
"We appreciated the ability of the team at ReportedHealth to quickly understand the ideal positioning of our product via literature reviews in the crowded indication" - Global Market Access Director (Big Pharma Client)
Rare Disease Asset
"ReportedHealth went the distance in the advisory boards to identify the meaningfulness of the biomarker to the patient's QoL which was critical for the successful market access story for our product" - EU Market Access Director (Small Biotech Client)
Opioid Addiction Asset
"The economic models developed by ReportedHealth were transparent and easy to use in our HTA submissions. Their Dossier writing team was also excellent" - Global HEOR Director (Mid-Size Pharma Client)